Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WBSCR27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AKAP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4271 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOBEC3G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANKEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KMT2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPSB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDST4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPT1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGKH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on